FKBP5 rs7356537: Stress Response and Cortisol Dynamics
The genetic variant rs7356537 is a single nucleotide polymorphism located within an intron of the FKBP5 gene on chromosome 6. Research suggests it acts as a regulatory variant that may alter chromatin conformation and modulate the efficiency of glucocorticoid receptor signaling following stress. Individuals carrying specific alleles may experience differences in post-stress cortisol clearance, although overall clinical evidence for this single site remains limited.
What each genotype means
Typical cortisol recovery pattern
You carry two copies of the common C allele for rs7356537 in the FKBP5 gene. In published stress response research, this genotype is generally associated with standard glucocorticoid receptor sensitivity and typical cortisol recovery dynamics following acute psychological stress. Because the overall scientific evidence for rs7356537 specifically is limited, this genotype alone does not determine your stress tolerance or emotional health.
Carried by approximately 81% of individuals in European populations, making it the predominant genotype across most studied groups.
Intermediate stress hormone response
You carry one copy of the T allele for rs7356537 in FKBP5. Preliminary research suggests this variant allele may be linked to subtle chromatin conformation differences that slightly prolong post-stress cortisol elevation. However, these associations represent population-level statistics from limited study cohorts rather than a clinical diagnosis of stress susceptibility or HPA-axis dysfunction.
Found in approximately 18% of people of European ancestry and present at modest frequencies globally.
Altered post-stress cortisol dynamics
You carry two copies of the less common T allele for rs7356537 in FKBP5. Research indicates that the T allele may interact with glucocorticoid regulatory elements to affect FKBP5 transcription, which has been linked in preliminary studies to extended elevation of cortisol levels following acute stress. Because current clinical evidence remains limited and heavily influenced by environmental factors such as life stress, this variant should not be interpreted as a medical diagnosis.
Carried by roughly 1% of individuals of European descent, reflecting its status as an uncommon homozygous genotype.
Molecular Profile and Genomic Context
The single nucleotide polymorphism rs7356537 is located in an intronic non-coding region of the FKBP5 gene on chromosome 6p21.31. In the standard human reference genome, this variant features an exchange between a cytosine (C) and a thymine (T) allele on the forward strand. Because it sits within an intron rather than a protein-coding exon, rs7356537 does not alter the amino acid sequence of the FKBP51 protein directly. Instead, research indicates that it lies within a genomic region containing distal regulatory elements, including potential glucocorticoid response elements. Through chromosome conformation capture and functional genomics studies, variants in this region of FKBP5 have been shown to influence physical loop formation between distant enhancer elements and the gene's core promoter. This altered structural topology can influence transcriptional responsiveness when cellular stress triggers the activation of steroid hormone pathways.
The Biological Role of the FKBP5 Gene
The FKBP5 gene encodes FK506-binding protein 51 (FKBP51), a critical molecular co-chaperone that partners with heat shock protein 90 (Hsp90) to regulate the sensitivity of the glucocorticoid receptor (GR). Under resting conditions, FKBP51 binds to the receptor complex in the cytoplasm, reducing its affinity for cortisol and slowing its translocation to the nucleus. When circulating cortisol surges during an acute stress response, cortisol binds to the GR, prompting FKBP51 to dissociate and allowing the receptor to enter the nucleus to activate stress-modulating target genes. One of the direct transcriptional targets of activated GR is FKBP5 itself, creating an ultra-short intracellular negative feedback loop designed to restore cellular equilibrium. When FKBP5 transcription is abnormally heightened or persistently sustained, it can dampen glucocorticoid sensitivity and interfere with the systemic negative feedback of the hypothalamic-pituitary-adrenal (HPA) axis.
Scientific Evidence and Stress Associations
Scientific research into FKBP5 polymorphisms has focused primarily on how regulatory variants modulate physiological recovery following acute psychological stress. In laboratory paradigms such as the Trier Social Stress Test (TSST), carriers of specific regulatory alleles in FKBP5 have demonstrated delayed termination of the cortisol response, leading to prolonged post-stress cortisol elevation and altered neuroendocrine curves. Variant rs7356537 has been evaluated as part of functional haplotypes and chromatin-looping frameworks that alter FKBP5 induction in response to glucocorticoids. However, the evidence specifically tying rs7356537 alone to clinical phenotypes—such as major depressive disorder or post-traumatic stress disorder—remains limited and relies heavily on candidate-gene studies. Genome-wide association studies (GWAS) often show modest or non-significant population-level signals for individual intronic SNPs when unlinked from broader environmental contexts, underscoring that gene-environment interactions, childhood adversity, and epigenetic methylation patterns strongly shape final physiological outcomes.
Population Frequency and Allelic Distribution
Allele frequencies for rs7356537 vary noticeably across global ancestral groups, as documented by large-scale genomic databases such as gnomAD. In populations of European ancestry, the minor allele frequency is approximately 0.10 (10%), meaning that around 18% to 19% of individuals carry at least one copy of the minor allele, while fewer than 2% are homozygous. Frequencies differ across other ancestral groups, with some East Asian and African cohorts displaying distinct distribution profiles for this haplotype block. Because this variant often occurs in linkage disequilibrium with other well-characterized regulatory SNPs in FKBP5—such as rs1360780—its physiological correlates are frequently inherited together as part of conserved regional haplotypes rather than operating in complete isolation.
Interpreting Your Genetic Results
Finding your rs7356537 genotype provides educational context regarding the biological pathways governing steroid hormone signaling, but it is not a clinical diagnosis. This variant is not a medical determinant of anxiety, depressive disorders, or chronic fatigue. Stress reactivity is an intensely polygenic trait influenced by thousands of genetic loci interacting with childhood environment, physical health, sleep patterns, and daily psychological demands. Genetic test results for rs7356537 cannot predict individual disease risk or dictate medical treatments. Furthermore, individuals undergoing pharmacological treatment involving glucocorticoids or psychotropic medications should never adjust dosages or discontinue therapies based on direct-to-consumer genetic data; any therapeutic modifications must be evaluated with a qualified physician or clinical pharmacist.
How common is this variant?
The minor allele frequency for rs7356537 is approximately 0.10 in populations of European ancestry according to gnomAD datasets, with the homozygous minor genotype occurring in roughly 1% of that population.
Frequently asked questions
Does having the rs7356537 variant mean I have high cortisol?
No. Genetic variants in FKBP5 do not set baseline cortisol levels in a direct or predictable way. Instead, they are studied for how efficiently the body turns off cortisol production after an acute stressor. Routine blood cortisol levels are governed primarily by circadian rhythms, overall health, and day-to-day stress, not by this single DNA change.
Can rs7356537 diagnose depression or anxiety?
No, this genetic variant cannot be used to diagnose any psychiatric or medical condition. Mood disorders and stress-related conditions arise from complex combinations of hundreds of genetic variants, life experiences, trauma, and lifestyle factors. Clinical diagnoses require comprehensive evaluation by a qualified medical provider.
What is the difference between rs7356537 and rs1360780?
Both are intronic single nucleotide polymorphisms located within the FKBP5 gene that participate in the regulation of glucocorticoid receptor activity. While rs1360780 is one of the most widely published variants in stress research, rs7356537 resides in the same broader genomic neighborhood and is frequently studied as part of co-inherited functional haplotypes influencing chromatin structure.
Can lifestyle interventions change how the FKBP5 gene works?
While lifestyle changes do not alter your underlying DNA sequence, research shows that FKBP5 is highly dynamic and subject to epigenetic modifications such as DNA methylation. Evidence-based habits such as regular aerobic exercise, adequate sleep, cognitive behavioral therapy, and mindfulness practices can support healthy hypothalamic-pituitary-adrenal axis regulation regardless of genotype.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs7356537?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FKBP5
This intronic variant in the FKBP5 gene modulates glucocorticoid receptor sensitivity and is linked to altered stress reactivity and susceptibility to psychiatric conditions like PTSD and depression.
Intronic variant in FKBP5; while FKBP5 is a well-established stress-response gene, specific associations for rs4713919 with HPA axis dynamics are less robustly replicated than other variants like rs1360780.
Modulates FKBP5 chaperone expression and alters glucocorticoid receptor sensitivity and negative feedback regulation of the HPA axis.
Regulatory variant in FKBP5 affecting glucocorticoid receptor chaperone activity and susceptibility to stress-related neuropsychiatric outcomes.
Functional polymorphism in FKBP5 that modulates ultradian and stress-induced cortisol secretion and alters recovery trajectories following acute psychological stress.
Intronic regulatory variant within FKBP5 linked to altered glucocorticoid receptor sensitivity and acute cortisol response following psychosocial stress.